You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TACTILE GRAPHIC PRINTER PROJECT (TGPP)
SBC: Automated Functions, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
GLUCARATE REDUCTION OF SERUM CHOLESTEROL
SBC: Biochemix, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
COST EFFECTIVE MANAGEMENT OF CARDIAC REHAB ON
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
BIOFILM INHIBITING COATING FOR URETHRAL CATHETERIZATION
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
NOVEL EXTERNAL URINARY COLLECTION SYSTEM
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
TREATMENT FOR GBS COLONIZATION IN PREGNANT WOMEN
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
ONE STEP ANTIMICROBIAL SURGICAL PREPARATION AND DRAPE
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
NOVEL SKIN PORT DEVICE FOR BLOOD GLUCOSE SENSING
SBC: Biotex, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
ADENOSINE ANTAGONIST FOR CARDIOPULMONARY RESUSCITATION
SBC: Discovery Therapeutics, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
IMMUNOGLOBULIN COATINGS TO PREVENT CATHETER INFECTION
SBC: GAMMA-A TECHNOLOGIES, INC. Topic: N/ACatheters are one of the most commonly used biomaterial implants, (200 million annually in the U.S.). In long term use as for vascular central lines, the urinary tract and peritoneal dialysis, catheters are particularly susceptible to infection. These infections are resistant to antibiotic treatment and persist until removal of the device. Utilizing the concept of Passive Local Immunotherapy, (PL ...
SBIR Phase I 1997 Department of Health and Human Services